Cargando…
How Do Iranian Stakeholders Think About Pharmaceutical Managed Entry Agreements?
BACKGROUND: Uncertainty in real-world product profiles is the main barrier to pharmaceutical market access. Managed entry agreements (MEAs) are the formal arrangements to overcome these uncertainties. Despite the extensive experience of developed countries in implementing such agreements, the experi...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Brieflands
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9420212/ https://www.ncbi.nlm.nih.gov/pubmed/36060922 http://dx.doi.org/10.5812/ijpr-126916 |